MediumEndocrinologyType 2 diabetes with cardiovascular diseaseca-mccqe1ca-rcpsc-im
A 60-year-old woman with type 2 diabetes and established coronary artery disease has been on maximally tolerated metformin for 9 months. Her HbA1c remains 8.3 percent despite excellent adherence. Estimated glomerular filtration rate is 80 mL/min/1.73 m². According to Diabetes Canada, which additional agent is preferred to improve both glycaemic control and cardiovascular outcomes?